How Sōlaria Biō is positioning Bōndia for credibility in a crowded bone health market
Sōlaria Biō validates gut delivery and control of Bōndia microbes. Read what the study really means for bone health and medical foods.
Pharma & Biotech
Pharma & Biotech
Why Sōlaria Biō’s new gut–bone research could disrupt standard osteoporosis care
Sōlaria Biō has disclosed new mechanistic data showing that its synbiotic medical food, Bondia, reinforces gut barrier integrity, reduces systemic inflammation, and suppresses osteoclast activity—offering biological insight into the 85 percent improvement in bone density reported in a prior large-scale clinical trial. These results support Bondia’s positioning as a novel intervention for osteopenia and age-related